Arshad M. Khanani
Chair of Retina Scientific Advisory Board & Independent DirectorDr. Arshad M. Khanani, MD, MA, FASRS, was Member of Clinical Advisory Board of Aviceda Therapeutics, Inc. Dr. Khanani is Member of Scientific Advisory Board of RevOpsis Therapeutics, Inc. Dr. Khanani is Member of Scientific Advisory Board of Clearside Biomedical, Inc. since April 2023. Dr. Khanani was Member of Advisory Board of RevOpsis Therapeutics, Inc. Dr. Khanani was Chair of Ophthalmology Advisory Board of 4D Molecular Therapeutics, Inc. from August 2024 to March 2026 and serves as its Chair of Retina Advisory Board from March 2026. Dr. Khanani serves as Member of Clinical Advisory Board at Surrozen, Inc. He has been Chief Medical Advisor & Chairman of Medical Advisory Board of Opthea Limited from 2024. Dr. Khanani was Scientific Advisory Board Member of Adverum Biotechnologies, Inc. He serves as Member of Ophthalmology Scientific Advisory Council at MERIT CRO, Inc. and Ocugen, Inc. Dr. Khanani is Scientific Advisor of Zip Bio, Inc. He is a Member of the Medical Advisory Board of Annexin Pharmaceuticals AB since September 2025. He is Member of Scientific Advisory Board of Ollin Biosciences Inc. He is Retina Advisor of Perfuse Therapeutics, Inc. Dr. Khanani has M.A. in Chemistry from Washington University, St. Louis. Dr. Khanani has B.A. in Chemistry from Washington University, St. Louis. Arshad M. Khanani, MD, MA, FASRS is a Managing Partner, Director of Clinical Research and Director of Fellowship at Sierra Eye Associates and Clinical Associate Professor at the University of Nevada, Reno School of Medicine. Dr. Khanani founded the clinical research department at Sierra Eye Associates, which is now one of the leading clinical research centers in the country. He has served as a principal investigator for over 100 clinical trials and has been a top enroller in the country for multiple Phase 1-3 trials. In addition, Dr Khanani has been the first one to perform surgical procedures in multiple surgical clinical trials dealing with sustained delivery and gene therapy. He has over 75 scientific publications. Dr. Khanani also serves as a member of numerous national and international clinical trial steering committees as well as scientific advisory boards with the goal of bringing new treatment options for patients with retinal diseases. Dr. Khanani is frequently invited as a guest speaker at national and international meetings. Dr. Khanani is an elected member of the Macula Society, Retina Society and has received numerous awards of distinction. In 2019, he received the Nevada Business Magazine Healthcare Heroes Physician of the Year award for his continued dedication to the field of ophthalmology. He is a Member of Medical Advisory Board at Opus Genetics, Inc. (formerly known as Ocuphire Pharma, Inc.) since March 2024. He has received the Senior Honor Award from the American Society of Retina Specialists (ASRS) and was also awarded the prestigious ASRS Presidents’ Young Investigator Award in 2021.
Positions
- Company NameOculis Holding AGStock CodeOCSPositionChair of Retina Scientific Advisory Board & Independent DirectorRelated SecuritiesColleagues
- RSRiad SherifCEO & Director
- AAAnthony A. RosenbergIndependent Chairman
- SCSylvia CheungChief Financial Officer
- GBGudrun BachmannChief Technology Officer
- BTBjorn TackenbergChief Scientific Officer
- KAKatie A. KazemChief Legal & Compliance Officer
- GOGeraldine O'KeeffeIndependent Director
- EDEric D. DonnenfeldChair of Cornea Scientific Advisory Board
